AU2001269264A1 - Base analogues - Google Patents

Base analogues

Info

Publication number
AU2001269264A1
AU2001269264A1 AU2001269264A AU6926401A AU2001269264A1 AU 2001269264 A1 AU2001269264 A1 AU 2001269264A1 AU 2001269264 A AU2001269264 A AU 2001269264A AU 6926401 A AU6926401 A AU 6926401A AU 2001269264 A1 AU2001269264 A1 AU 2001269264A1
Authority
AU
Australia
Prior art keywords
alkynyl
sugar
base analogues
alkenyl
novel compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001269264A
Other languages
English (en)
Inventor
Dan Brown
Shiv Kumar
David Loakes
Mark Mcdougall
Satyam Nampalli
Constantin Neagu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare UK Ltd
Original Assignee
Amersham Biosciences UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amersham Biosciences UK Ltd filed Critical Amersham Biosciences UK Ltd
Publication of AU2001269264A1 publication Critical patent/AU2001269264A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/23—Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
    • C12Q2525/10—Modifications characterised by
    • C12Q2525/117—Modifications characterised by incorporating modified base

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Laminated Bodies (AREA)
  • Photoreceptors In Electrophotography (AREA)
AU2001269264A 2000-07-03 2001-06-29 Base analogues Abandoned AU2001269264A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0016258.6A GB0016258D0 (en) 2000-07-03 2000-07-03 Base analogues
GB0016258 2000-07-03
PCT/GB2001/002890 WO2002002584A1 (en) 2000-07-03 2001-06-29 Base analogues

Publications (1)

Publication Number Publication Date
AU2001269264A1 true AU2001269264A1 (en) 2002-01-14

Family

ID=9894887

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001269264A Abandoned AU2001269264A1 (en) 2000-07-03 2001-06-29 Base analogues

Country Status (11)

Country Link
US (1) US6664058B2 (ja)
EP (1) EP1296997B1 (ja)
JP (1) JP2004502701A (ja)
AT (1) ATE339434T1 (ja)
AU (1) AU2001269264A1 (ja)
CA (1) CA2412292A1 (ja)
DE (1) DE60123056T2 (ja)
DK (1) DK1296997T3 (ja)
ES (1) ES2271036T3 (ja)
GB (1) GB0016258D0 (ja)
WO (1) WO2002002584A1 (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6780591B2 (en) 1998-05-01 2004-08-24 Arizona Board Of Regents Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
US7875440B2 (en) 1998-05-01 2011-01-25 Arizona Board Of Regents Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
US7169560B2 (en) 2003-11-12 2007-01-30 Helicos Biosciences Corporation Short cycle methods for sequencing polynucleotides
ATE463584T1 (de) 2004-02-19 2010-04-15 Helicos Biosciences Corp Verfahren zur analyse von polynukleotidsequenzen
US7666593B2 (en) 2005-08-26 2010-02-23 Helicos Biosciences Corporation Single molecule sequencing of captured nucleic acids
CN111818877B (zh) 2018-01-25 2023-12-22 爱德华兹生命科学公司 在部署后用于辅助置换瓣膜重新捕获和重新定位的递送系统
JP2021534101A (ja) 2018-08-09 2021-12-09 ヴェルソー セラピューティクス， インコーポレイテッド Ｃｃｒ２及びｃｓｆ１ｒを標的とするためのオリゴヌクレオチド組成物ならびにその使用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9602025D0 (en) * 1996-02-01 1996-04-03 Amersham Int Plc Nucleoside analogues
GB9716231D0 (en) * 1997-07-31 1997-10-08 Amersham Int Ltd Base analogues

Also Published As

Publication number Publication date
JP2004502701A (ja) 2004-01-29
CA2412292A1 (en) 2002-01-10
DE60123056T2 (de) 2007-01-18
DE60123056D1 (de) 2006-10-26
ATE339434T1 (de) 2006-10-15
DK1296997T3 (da) 2007-01-02
GB0016258D0 (en) 2000-08-23
EP1296997A1 (en) 2003-04-02
US6664058B2 (en) 2003-12-16
US20020137695A1 (en) 2002-09-26
WO2002002584A1 (en) 2002-01-10
ES2271036T3 (es) 2007-04-16
EP1296997B1 (en) 2006-09-13

Similar Documents

Publication Publication Date Title
CA2283509A1 (en) Novel bicyclonucleoside and oligonucleotide analogue
ATE232880T1 (de) Neue nucleotidanaloga
MXPA02011896A (es) Produccion combinatoria de analogos de nucleotidos y nucleosidos (xitp).
WO2001038584A3 (en) Non-aggregating, non-quenching oligomers comprising nucleotide analogues; methods of synthesis and use thereof
CA2274464A1 (en) Ketobenzamides as calpain inhibitors
WO1999006422A3 (en) Base analogues
IL152673A0 (en) Nucleotide analogues comprising a reporter moiety and a polymerase enzyme blocking moiety
EP2116600A3 (en) Method for synthesizing DNA
WO2000061151A3 (en) Oligodeoxynucleotide and its use to induce an immune response
CA2414095A1 (en) Novel compounds
EP1754703A3 (en) N-Heterocyclic derivatives as nos inhibitors
CA2278201A1 (en) Novel modifications to 2-amino-4-(4-fluorobenzylamino)-1-ethoxycarbonyl-aminobenzene, and processes for their preparation
WO2003014080A3 (en) Oxopyrrolidine compounds, preparation of said compounds and their use in the manufacturing of levetiracetam and analogues
EP2157083A3 (en) Pharmaceutical compositions containing crystalline form (I) of lercanidipine hydrochloride
EP1077218A3 (en) Peptido-mimetic compounds containing RGD sequence useful as integrin inhibitors
AU2001269264A1 (en) Base analogues
CA2442210A1 (en) Aryl oxime-piperazines useful as ccr5 antagonists
WO1999037291A3 (de) Verwendung von substituierten sulfonamiden als antivirale mittel und neue stoffe
WO2002044398A3 (en) Universal supports for oligonucleotide synthesis
WO2000049022A3 (en) Organosilicon compounds and uses thereof
AU2002333558A1 (en) Methods of selecting 5'-capped nucleic acid molecules
WO2001051486A3 (en) Process and intermediates for the preparation of imidazopyridines
WO2004028445A3 (en) Processes for preparing 1,3-dioxolane nucleosides
WO2002008247A3 (en) Process for the preparation of 5-phenylpentanoyl-ala-argl-{2-[3-amino-2-oxopyrrolidin-1-yl]propionyl}-ala-arg-ala-4-aminophenylacetamide
EP1312608A3 (en) Discodermolide analogues and their pharmaceutical use